Cargando…
Kainate Receptor Antagonists: Recent Advances and Therapeutic Perspective
Since the 1990s, ionotropic glutamate receptors have served as an outstanding target for drug discovery research aimed at the discovery of new neurotherapeutic agents. With the recent approval of perampanel, the first marketed non-competitive antagonist of AMPA receptors, particular interest has bee...
Autores principales: | Chałupnik, Paulina, Szymańska, Ewa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916396/ https://www.ncbi.nlm.nih.gov/pubmed/36768227 http://dx.doi.org/10.3390/ijms24031908 |
Ejemplares similares
-
Discovery of the First Highly Selective Antagonist of the GluK3 Kainate Receptor Subtype
por: Chałupnik, Paulina, et al.
Publicado: (2022) -
Therapeutic Potential of Kainate Receptors
por: Matute, Carlos
Publicado: (2010) -
Trafficking of Kainate Receptors
por: Pahl, Steffen, et al.
Publicado: (2014) -
Topiramate and other kainate receptor antagonists for depression: A systematic review of randomized controlled trials
por: Shamabadi, Ahmad
Publicado: (2022) -
Cortical kainate receptors and behavioral anxiety
por: Zhuo, Min
Publicado: (2017)